欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/1047/001
药品名称XALOPTIC NEO 50 μg/ml Eye drops, solution
活性成分
    • Latanoprost 50.0 µg/ml
剂型Eye drops, solution
上市许可持有人Warszawskie Zaklady Farmaceutyczne Polfa S.A., Ul. Karolkowa 22/24 Warszawa 1-207 Poland
参考成员国 - 产品名称Czechia (CZ)
XALOPTIC NEO 50 μg/ml oční kapky, roztok
互认成员国 - 产品名称
    • Portugal (PT)
    • Italy (IT)
    • Latvia (LV)
      Xalvide 50 mikrogrami/ml acu pilieni, šķīdums
    • Lithuania (LT)
      Xalvide 50 mikrogramų/ml akių lašai (tirpalas)
    • Bulgaria (BG)
      Latanoprost Polfa
    • Germany (DE)
      Latanoprost Polpharma 50 μg/ml Augentropfen, Lösung
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
许可日期2021/10/21
最近更新日期2025/01/16
药物ATC编码
    • S01EE01 latanoprost
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase